VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
DRMA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
DRMADermata Therapeutics, Inc.
$1.30$886024
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksDRMAQuarterly Financials

Dermata Therapeutics, Inc. (DRMA) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Dermata Therapeutics, Inc. (DRMA) quarterly income statement — complete revenue, gross profit & net income history

DRMA Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold00000000000000000000
COGS % of Revenue--------------------
Gross Profit00000000000000000000
Gross Margin %--------------------
Gross Profit Growth %--------------------
Operating Expenses1.93M1.9M1.76M1.77M2.34M3.2M3.23M2.88M3.2M2.22M1.81M1.73M2.28M1.71M2.45M2.73M2.79M2.55M1.71M1.33M
OpEx % of Revenue--------------------
Selling, General & Admin1.54M1.37M1.26M1.15M1.06M1.01M824.29K874.64K1.6M1.08M909K893.48K1.09M822.33K892.78K1.12M1.19M1.44M912.49K462.77K
SG&A % of Revenue--------------------
Research & Development383.72K526.62K504.39K617.84K1.28M2.19M2.4M2.01M1.6M1.14M902.98K838.93K1.19M889.36K1.55M1.61M1.6M1.11M799.78K867.2K
R&D % of Revenue--------------------
Other Operating Expenses000000000023000000000
Operating Income-1.93M-1.9M-1.76M-1.77M-2.34M-3.2M-3.23M-2.88M-3.2M-2.22M-1.81M-1.73M-2.28M-1.71M-2.45M-2.73M-2.79M-2.55M-1.71M-1.33M
Operating Margin %--------------------
Operating Income Growth %17.67%40.62%45.42%38.53%26.96%-44.16%-78.02%-66.46%-40.65%-29.7%25.92%36.56%18.25%32.95%-42.86%-105.34%-23.17%-419.48%--
EBITDA-1.93M-1.9M-1.76M-1.77M-2.34M-3.15M-3.17M-2.83M-3.13M-2.13M0-1.7M-2.24M-1.67M-2.42M00-2.55M-1.71M-1.33M
EBITDA Margin %--------------------
EBITDA Growth %17.67%39.69%44.51%37.34%25.35%-47.66%--66.28%-39.91%-27.81%100%--34.6%-41.6%100%100%-613.42%--
D&A (Non-Cash Add-back)00000000001.81M00002.73M2.79M000
EBIT-1.93M-1.9M-1.76M-1.77M-2.34M-3.15M-3.17M-2.83M-3.13M-2.13M-1.81M-1.7M-2.24M-1.67M-2.42M-2.73M-2.79M-2.55M-1.71M-1.33M
Net Interest Income78.68K38.51K68.68K71.64K36.22K49.35K52.5K54.64K69.3K85.86K92.77K31.05K37.54K42.09K21.49K00-45.57M-651-1.82K
Interest Income78.68K38.51K68.68K71.64K36.22K49.35K52.5K54.64K69.3K85.86K92.77K31.05K37.54K42.09K21.49K00000
Interest Expense0000000000000000045.57M6511.82K
Other Income/Expense78.68K38.51K68.68K71.64K36.22K49.35K52.5K54.64K69.3K85.86K92.77K31.05K37.54K42.09K21.49K000-651-1.82K
Pretax Income-1.85M-1.86M-1.69M-1.7M-2.3M-3.15M-3.17M-2.83M-3.13M-2.13M-1.72M-1.7M-2.24M-1.67M-2.42M-2.73M-2.79M-2.55M-1.71M-1.33M
Pretax Margin %--------------------
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-1.85M-1.86M-1.69M-1.7M-2.3M-3.15M-3.17M-2.83M-3.13M-2.13M-1.72M-1.7M-2.24M-1.67M-2.42M-2.73M-2.79M-2.55M-1.71M-1.33M
Net Margin %--------------------
Net Income Growth %19.79%40.91%46.68%39.87%26.5%-47.65%-84.59%-66.28%-39.91%-27.81%29.1%37.7%19.59%34.6%-41.55%-105.06%-20.87%-544.15%--
Net Income (Continuing)-1.85M-1.86M-1.69M-1.7M-2.3M-3.15M-3.17M-2.83M-3.13M-2.13M-1.72M-1.7M-2.24M-1.67M-2.42M-2.73M-2.79M-2.55M-1.71M-1.33M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.48-1.52-1.65-1.66-4.47-20.40-20.40-41.82-70.58-5.40-80.86-94.30-340.80-20.60-474.00-585.00-802.50-3.10-2064.00-425.30
EPS Growth %89.26%92.55%91.91%96.03%93.67%-277.78%74.77%55.65%79.29%73.79%82.94%83.88%57.53%-564.52%77.03%-37.55%-20.82%-551.26%--
EPS (Basic)-0.48-1.52-1.65-1.66-4.47-20.40-20.40-41.82-70.58-5.40-80.86-94.30-340.80-20.60-474.00-585.00-802.50-3.10-2064.00-425.30
Diluted Shares Outstanding3.86M1.22M1.03M1.03M515.5K155.5K155.5K67.66K44.41K393.1K21.26K18.03K6.57K77.01K5.12K4.67K52.2K835.2K31.13K46.97K
Basic Shares Outstanding3.86M1.22M1.03M1.03M515.5K155.5K155.5K67.66K44.41K393.1K21.26K270.5K6.57K77.01K5.12K69.97K52.05K835.2K31.13K46.97K
Dividend Payout Ratio--------------------